PROGNOSTIC-SIGNIFICANCE OF FLOW-CYTOMETRY STUDIES IN B-CELL NON-HODGKIN-LYMPHOMA

被引:49
|
作者
REHN, S
GLIMELIUS, B
STRANG, P
SUNDSTROM, C
TRIBUKAIT, B
机构
[1] KAROLINSKA INST, DEPT MED RADIOBIOL, S-10401 STOCKHOLM 60, SWEDEN
[2] UNIV UPPSALA, AKAD SJUKHUSET, DEPT PATHOL, S-75185 UPPSALA, SWEDEN
关键词
DNA‐measurement; Flow cytometry; Non‐Hodgkin lymphoma; Prognosis; S‐phase rate;
D O I
10.1002/hon.2900080102
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The prognostic relevance of flow cytometric DNA measurements of lymph node biopsies in relation to histopathology according to the Kiel classification, stage, age and presence or absence of B‐symptoms was investigated in 106 patients with non‐Hodgkin lymphomas (NHL) of proven B‐cell type. Biopsies were taken at diagnosis before treatment. The mean proportion of cells in S‐phase was significantly lower in the 76 patients with a ‘low grade’ NHL (4.4 per cent) than in the 30 patients with a ‘high grade’ NHL (13.0 per cent) (p<0.0001). High S‐phase rates were associated with a poor prognosis within the whole material (p<0.01) and within the group of ‘high grade’ NHL (p<0.05). In the subgroup CB‐CC lymphomas of ‘low grade’ NHL, the prognostic value of the S‐phase rate was stronger than any other investigated parameter (p<0.05). In multivariate analyses, the S‐phase rate gave, in several subgroups, independent prognostic information, besides clinico‐pathological variables. Copyright © 1990 John Wiley & Sons, Ltd
引用
收藏
页码:1 / 12
页数:12
相关论文
共 50 条
  • [1] PROGNOSTIC-SIGNIFICANCE OF DNA-ANALYSIS BY FLOW-CYTOMETRY IN NON-HODGKINS-LYMPHOMA
    ROOS, G
    DIGE, U
    LENNER, P
    LINDH, J
    JOHANSSON, H
    HEMATOLOGICAL ONCOLOGY, 1985, 3 (04) : 233 - 242
  • [2] PROGNOSTIC-SIGNIFICANCE OF FLOW-CYTOMETRY IN NON-SMALL-CELL LUNG-CANCER
    RICE, TW
    BAUER, TW
    GEPHARDT, GN
    MEDENDORP, SV
    MCLAIN, DA
    KIRBY, TJ
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1993, 106 (02): : 210 - 217
  • [3] FLOW-CYTOMETRY OF NON-SMALL-CELL BRONCHOGENIC-CARCINOMA AND ITS PROGNOSTIC-SIGNIFICANCE
    LIEWALD, F
    SUNDERPLASSMANN, L
    VALET, G
    WULF, G
    WEISS, M
    SCHILDBERG, FW
    CHIRURG, 1992, 63 (03): : 205 - 210
  • [4] FACTORS CONTRIBUTING TO THE PROGNOSTIC-SIGNIFICANCE OF BONE-MARROW INVOLVEMENT IN CHILDHOOD NON-HODGKIN-LYMPHOMA
    SANDLUND, JT
    RIBEIRO, R
    LIN, JS
    AYERS, D
    SANTANA, VM
    FURMAN, WL
    MAHMOUD, H
    BERARD, CW
    HUTCHISON, RE
    CRIST, WM
    RAFFERTY, M
    PUI, CH
    MEDICAL AND PEDIATRIC ONCOLOGY, 1994, 23 (04): : 350 - 353
  • [5] FLOW-CYTOMETRY IN HUMAN ADENOCARCINOMA OF THE LUNG - PROGNOSTIC-SIGNIFICANCE FOR SURVIVAL
    VOLM, M
    MATTERN, J
    MULLER, T
    VOGTMOYKOPF, I
    TUMORDIAGNOSTIK & THERAPIE, 1988, 9 (05) : 177 - 181
  • [6] FLOW-CYTOMETRY ANALYSIS OF MURINE B-CELL LYMPHOMA DIFFERENTIATION
    WARNER, NL
    DALEY, MJ
    RICHEY, J
    SPELLMAN, C
    IMMUNOLOGICAL REVIEWS, 1979, 48 : 197 - 243
  • [7] FLOW CYTOMETRY (FCM) AND PROGNOSTIC FACTORS EVALUATION IN CLL AND B-CELL NON-HODGKIN LYMPHOMA (NHL)
    Durrieu, Francoise
    Genevieve, Franck
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2009, 76B (06) : 422 - 422
  • [8] LONG-TERM CULTURE OF B-CELL NON-HODGKIN-LYMPHOMA
    BUSKE, C
    SCHREIBER, K
    GEHLMANN, B
    HARBOTT, J
    HIDDEMANN, W
    WORMANN, B
    BLOOD, 1993, 82 (10) : A561 - A561
  • [9] PROGNOSTIC-SIGNIFICANCE OF IMMUNOGLOBULIN ISOTYPE EXPRESSION IN B-CELL NON-HODGKINS LYMPHOMA
    LINDEMALM, C
    CHRISTENSSON, B
    BIBERFELD, G
    BIBERFELD, P
    BJORKHOLM, M
    JOHANSSON, B
    KIMBY, E
    MELLSTEDT, H
    MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1988, 5 (04): : 243 - 248
  • [10] Flow Cytometry for B-Cell Non-Hodgkin and Hodgkin Lymphomas
    Gajzer, David C.
    Fromm, Jonathan R.
    CANCERS, 2025, 17 (05)